Legal & General Group
QTTB icon

Legal & General Group’s Q32 Bio QTTB Stock Holding History

Legal & General Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-523
Closed -$863 – 3568
2025
Q1 		$863 Hold
523
– – ﹤0.01% 3372
2024
Q4 		$1.8K Hold
523
– – ﹤0.01% 3382
2024
Q3 		$23.3K Hold
523
– – ﹤0.01% 2991
2024
Q2 		$9.39K Buy
+523
New +$12.5K ﹤0.01% 3311
2022
Q3 		– Sell
-186
Closed -$7K – 3494
2022
Q2 		$7K Sell
186
-1,714
-90% -$58.5K ﹤0.01% 3424
2022
Q1 		$103K Hold
1,900
– – ﹤0.01% 2860
2021
Q4 		$125K Buy
1,900
+1,206
+174% +$117K ﹤0.01% 2862
2021
Q3 		$98K Buy
694
+407
+142% +$51.8K ﹤0.01% 2850
2021
Q2 		$38K Buy
287
+36
+14% +$4.49K ﹤0.01% 3049
2021
Q1 		$43K Sell
251
-8
-3% -$1.69K ﹤0.01% 2862
2020
Q4 		$53K Hold
259
– – ﹤0.01% 2784
2020
Q3 		$50K Sell
259
-79
-23% -$17.7K ﹤0.01% 2698
2020
Q2 		$92K Buy
338
+91
+37% +$24.3K ﹤0.01% 2555
2020
Q1 		$70K Sell
247
-63
-20% -$19.3K ﹤0.01% 2504
2019
Q4 		$115K Buy
310
+58
+23% +$16.6K ﹤0.01% 2554
2019
Q3 		$82K Hold
252
– – ﹤0.01% 2585
2019
Q2 		$89K Buy
252
+77
+44% +$30.3K ﹤0.01% 2572
2019
Q1 		$88K Hold
175
– – ﹤0.01% 2530
2018
Q4 		$71K Buy
175
+89
+103% +$33.7K ﹤0.01% 2568
2018
Q3 		$35K Hold
86
– – ﹤0.01% 2956
2018
Q2 		$32K Buy
+86
New +$30.8K ﹤0.01% 2988

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group's QTTB Position: Q2 2025 in Review

Legal & General Group sold out of Q32 Bio (QTTB) in Q2 2025, closing a stake of 523 shares — an estimated $863 sold.

Legal & General Group first reported a position in QTTB in Q2 2018 and held it in 21 quarters. The position peaked at $125K in Q4 2021. 61 funds tracked by Wall St. Rank hold QTTB as of Q2 2025.

  • Legal & General Group reported no remaining Q32 Bio position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 523 Q32 Bio shares in Q2 2025, an estimated $863.
  • Legal & General Group first reported a position in Q32 Bio in Q2 2018 and held it in 21 quarters.
  • Legal & General Group's Q32 Bio position peaked at $125K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.